fkbma: An R Package for Detecting Tailoring Variables with Free-Knot B-Splines and Bayesian Model Averaging
fkbma:以自由节点 B 样条和贝叶斯模型平均识别治疗定制变量的 R 包AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确围绕处理效应异质性、治疗获益亚组及个性化治疗变量展开。
fkbma:以自由节点 B 样条和贝叶斯模型平均识别治疗定制变量的 R 包AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Precision medicine aims to optimize treatment by identifying patient subgroups most likely to benefit from specific interventions. To support this goal, we introduce fkbma, an R package that implements a Bayesian model averaging approach with free-knot B-splines for identifying tailoring variables. The package employs a reversible jump Markov chain Monte Carlo algorithm to flexibly model treatment effect heterogeneity while accounting for uncertainty in both variable selection and non-linear relationships. fkbma provides a comprehensive framework for detecting predictive biomarkers, integrating Bayesian adaptive enrichment strategies, and enabling robust subgroup identification in clinical trials and observational studies. This paper details the statistical methodology underlying fkbma, outlines its computational implementation, and demonstrates its application through simulations and real-world examples. The package's flexibility makes it a valuable tool for precision medicine research, offering a principled approach to treatment personalization.